Matthew Adams, MD
Retina Specialist · Plano, TXNPI 1124361076
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Alimera Sciences, Inc. at 48.2% of the total. Reporting peaked in 2024 at $15,088 and has fallen 69.8% since, to $4,560 in 2025.
Across 187 payments — averaging $164.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alimera Sciences, Inc.$15K
- Genentech USA, Inc.$5K
- Harrow Eye, LLC$3K
- Eyepoint US, Inc.$2K
- Carl Zeiss Meditec USA, Inc.$1K
- AbbVie$825
- plus $3K from 17 others
What the payments were for
- Consulting fees$6,10020%
- Speaking & faculty fees$13,69045%
- Travel & lodging$2,1407%
- Food & beverage$8,61928%
- Education$170%
- Entertainment$1170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alimera Sciences, Inc. | 31 | $14,780 |
| Genentech USA, Inc. | 34 | $4,884 |
| Harrow Eye, LLC | 6 | $3,122 |
| Eyepoint US, Inc. | 12 | $2,428 |
| Carl Zeiss Meditec USA, Inc. | 5 | $1,214 |
| AbbVie(2 entities) | 21 | $825 |
| ANI Pharmaceuticals, Inc. | 7 | $574 |
| Alcon | 5 | $537 |
| Regeneron Healthcare Solutions, Inc. | 22 | $456 |
| Astellas Pharma US Inc | 9 | $337 |
| Biotissue Holdings Inc. | 11 | $328 |
| Dutch Ophthalmic, USA | 4 | $292 |
| Apellis Pharmaceuticals, Inc. | 4 | $200 |
| Novartis | 5 | $148 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $138 |
| Bausch & Lomb Americas Inc. | 1 | $120 |
| Optos, Inc. | 1 | $117 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $93 |
| Akorn, Inc. | 1 | $23 |
| LKC Technologies, Inc. | 1 | $21 |
| Rxsight Inc | 1 | $18 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- YUTIQ$14,777
- Iluvien$14,407
- Lucentis$3,411
- IHEEZO$3,019
- TRIESENCE$2,800
- VABYSMO$743
- OZURDEX$394
- EVA Ophthalmic Surgical System$255
- SUSVIMO$254
- OCT OPHTHALMOSCOPE$235
- PANORAMIC OPHTHALMOSCOPE$235
- PURIFIED CORTROPHIN GEL$200
- Luxor$150
- Constellation$150
- AcrySof IQ PanOptix$150
- NGENUITY$137
- DEXYCU$134
- AcrySof IQ VIVITY IOL$121
- enVista MX60 IOL$120
- NFC-700$117
How this compares
$30,684 in reported general payments places this provider in the 85th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 110 | $3,865 |
| Ofloxacin | 81 | $912 |
| Latanoprost | 45 | $818 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $262 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Plano
- Hemang PandyaPlano$153K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
- Garvin DavisHouston$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.